Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Beyond Air, Inc. XAIR
$5.57
-$0.01 (-0.09%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
169263563.00000000
-
week52high
11.76
-
week52low
4.79
-
Revenue
0
-
P/E TTM
-3
-
Beta
-0.31349400
-
EPS
-1.98000000
-
Last Dividend
0.00000000
-
Next Earnings Date
26 июн 2023 г. в 10:59
Описание компании
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Truist Securities | Buy | Buy | 29 июн 2022 г. |
| Ladenburg Thalmann | Buy | Buy | 29 июн 2022 г. |
| Truist Securities | Buy | Buy | 12 ноя 2021 г. |
| Truist Securities | Buy | 28 апр 2021 г. | |
| Oppenheimer | Outperform | 22 окт 2019 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Carey Robert | A | 842323 | 20000 | 07 дек 2022 г. |
| Carey Robert | A | 822323 | 15000 | 29 ноя 2022 г. |
| Carey Robert | A | 807323 | 15000 | 28 ноя 2022 г. |
| Carey Robert | A | 792323 | 20000 | 18 ноя 2022 г. |
| Carey Robert | A | 772323 | 20000 | 17 ноя 2022 г. |
| Carey Robert | A | 752323 | 10000 | 16 ноя 2022 г. |
| Gaul Michael A. | A | 64150 | 2000 | 22 авг 2022 г. |
| BENTSUR RON | D | 142436 | 40000 | 30 июн 2022 г. |
| Avniel Amir | D | 13733 | 2600 | 30 июн 2022 г. |
| Avniel Amir | D | 408027 | 65500 | 30 июн 2022 г. |
Новостная лента
5 Stocks Insiders Have Built Positions in Over the Past 3 Months
GuruFocus
18 апр 2023 г. в 17:03
According to the Insider Cluster Buys Screen, a Premium feature of GuruFocus, five stocks that have high number of unique insider buys over the past three months are Air Transport Services Group Inc. ( ATSG , Financial), Beyond Air Inc. ( XAIR , Financial), Charles Schwab Corp. ( SCHW , Financial), Valley National Bancorp ( VLY , Financial) and NewtekOne Inc. ( NEWT , Financial).
Beyond Cancer™ to Present Two Posters for Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2023 AACR Annual Meeting
GlobeNewsWire
14 мар 2023 г. в 16:35
Proffered abstracts accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting were released publicly today at 4:30 PM EDT Proffered abstracts accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting were released publicly today at 4:30 PM EDT
Beyond Air® Announces Participation at Two Upcoming Investor Conferences in March 2023
GlobeNewsWire
22 февр 2023 г. в 07:00
GARDEN CITY, N.Y., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in two upcoming investor conferences in March 2023.
Beyond Air, Inc. (XAIR) Q3 2023 Earnings Call Transcript
Seeking Alpha
09 февр 2023 г. в 20:29
Beyond Air, Inc. (NASDAQ:XAIR ) Q3 2023 Earnings Conference Call February 9, 2023 4:30 PM ET Company Participants Edward Barger - Head, Investor Relations Steve Lisi - Chairman and CEO Duncan Fatkin - Chief Commercial Officer Douglas Larson - Chief Financial Officer Conference Call Participants Matt Kaplan - Ladenburg Thalmann Greg Fraser - Truist Securities Yale Jen - Laidlaw & Company Suraj Kalia - Oppenheimer & Company Operator Good afternoon. And welcome everyone to the Beyond Air Financial Results Call for the Third Fiscal Quarter ended December 31, 2022.
Beyond Air, Inc. (XAIR) Reports Q3 Loss, Lags Revenue Estimates
Zacks Investment Research
09 февр 2023 г. в 18:50
Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -2.38% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?